DK1506233T3 - Aktivt kompleks af alpha-lactalbumin (hamlet)samt co-faktor - Google Patents

Aktivt kompleks af alpha-lactalbumin (hamlet)samt co-faktor

Info

Publication number
DK1506233T3
DK1506233T3 DK03727868.6T DK03727868T DK1506233T3 DK 1506233 T3 DK1506233 T3 DK 1506233T3 DK 03727868 T DK03727868 T DK 03727868T DK 1506233 T3 DK1506233 T3 DK 1506233T3
Authority
DK
Denmark
Prior art keywords
hamlet
lactalbumin
alpha
factor
active complex
Prior art date
Application number
DK03727868.6T
Other languages
Danish (da)
English (en)
Original Assignee
Nya Hamlet Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nya Hamlet Pharma Ab filed Critical Nya Hamlet Pharma Ab
Application granted granted Critical
Publication of DK1506233T3 publication Critical patent/DK1506233T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK03727868.6T 2002-05-08 2003-05-08 Aktivt kompleks af alpha-lactalbumin (hamlet)samt co-faktor DK1506233T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210464.4A GB0210464D0 (en) 2002-05-08 2002-05-08 Therapeutic treatment
PCT/IB2003/002366 WO2003095490A1 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor

Publications (1)

Publication Number Publication Date
DK1506233T3 true DK1506233T3 (da) 2014-07-07

Family

ID=9936230

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03727868.6T DK1506233T3 (da) 2002-05-08 2003-05-08 Aktivt kompleks af alpha-lactalbumin (hamlet)samt co-faktor

Country Status (8)

Country Link
US (2) US7270822B2 (enExample)
EP (1) EP1506233B8 (enExample)
JP (1) JP2006500321A (enExample)
AU (1) AU2003233116B2 (enExample)
CA (1) CA2485223A1 (enExample)
DK (1) DK1506233T3 (enExample)
GB (1) GB0210464D0 (enExample)
WO (1) WO2003095490A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
EP1727561A1 (en) * 2004-02-26 2006-12-06 HAMLET Pharma AB Lactalbumin for inhibiting angiogenesis
GB0408752D0 (en) * 2004-04-20 2004-05-26 Hamlet Ltd Therapeutic treatment
EP1715334A1 (fr) * 2005-04-22 2006-10-25 Adamant Technologies SA Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
GB0518720D0 (en) * 2005-09-14 2005-10-19 Hamlet Pharma Ab Therapeutic combination
WO2009135494A2 (en) * 2008-05-09 2009-11-12 Nya Hamlet Pharma Ab Alpha-lactalbumin composition for the treatment of actinic keratosis
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348376A (en) 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
JP2961625B2 (ja) 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法
US6455673B1 (en) 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
DK0776214T3 (da) 1994-08-16 1999-11-29 Catharina Svanborg Antibakterialt præparat indeholdende multimert alfa-lactalbumin
US6159748A (en) 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5614191A (en) 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
JP2001524491A (ja) 1997-11-21 2001-12-04 カタリーナ・スヴァンボルイ ラクトアルブミン生産方法
GB9725126D0 (en) * 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
US20010044416A1 (en) 2000-01-20 2001-11-22 Mccluskie Michael J. Immunostimulatory nucleic acids for inducing a Th2 immune response
CA2404100A1 (en) 2000-03-24 2001-10-04 Filgen Biosciences, Inc. Therapeutic peptides having a motif that binds specifically to non-acetylated h3 and h4 histones for cancer therapy
AU2001261024A1 (en) * 2000-04-12 2001-10-30 Delta Biotechnology Limited Albumin fusion proteins
GB0205347D0 (en) * 2002-03-07 2002-04-24 Svanborg Catharina Biologically active complex
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
EP1727561A1 (en) * 2004-02-26 2006-12-06 HAMLET Pharma AB Lactalbumin for inhibiting angiogenesis

Also Published As

Publication number Publication date
EP1506233B1 (en) 2014-04-02
AU2003233116A1 (en) 2003-11-11
GB0210464D0 (en) 2002-06-12
JP2006500321A (ja) 2006-01-05
EP1506233B8 (en) 2014-09-24
AU2003233116B2 (en) 2009-03-26
US7270822B2 (en) 2007-09-18
WO2003095490A1 (en) 2003-11-20
US7713533B2 (en) 2010-05-11
US20080167233A1 (en) 2008-07-10
CA2485223A1 (en) 2003-11-20
EP1506233A1 (en) 2005-02-16
US20060074017A1 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
ATE472536T1 (de) Pyridin- und pyrimidin-derivate
FR2840523B1 (fr) Article multicouche absorbant et recurant
DE60326611D1 (de) N und dergleichen
AU2003256285A8 (en) Improved assay systems and components
AU2003274383A1 (en) Processor switching between secure and non-secure modes
AU2003292304A1 (en) Controlled structure copolymer comprising an amphoteric or zwitterionic part
AU2003213828A1 (en) Stent retention element and related methods
EP1485754A4 (en) VITRINE AND MERCHANDISE EXPOSURE SYSTEM
EP1474445A4 (en) ADIPONECTIN GLYCO-ISOFORMS, AND USES THEREOF
AU2003216591A1 (en) Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
BR0301985B1 (pt) copolímero de flúor, artigo e laminado
AU2003210043A1 (en) Advanced cell-transducing transport domain-target protein-transport domain fusion protein and uses thereof
EP1478761A4 (en) DEGRADATION OF PESTICIDES AND HYDROPHOBIC ESTERIC TOXINS
DK1506233T3 (da) Aktivt kompleks af alpha-lactalbumin (hamlet)samt co-faktor
DK1462455T3 (da) Ser-Ser-Ser-Arg-peptid samt medicinske anvendelser deraf
DE60318139D1 (de) Isolator- und Anordnungskonfiguration
AU2003241384A1 (en) Cyclic peptide anti-viral agents and methods
AU2003253414A1 (en) An oscillator and an integrated circuit
AU2003264844A1 (en) Methods of determining the effect of an agent on diploid cells and/or on the pattern of expression of polypeptides expressed therewith
GB0307190D0 (en) Security attributes of nodes in trusted computing systems
DE10196066T1 (de) Verzögerungsschaltung und Ringoszillator
AU2002251595A1 (en) Oscillator circuit and oscillator biasing method
AU2003272423A1 (en) Centrosome proteins and uses thereof
AU2003285686A1 (en) Glycoisoforms of adiponectin and uses thereof
AU2003222533A1 (en) Proteins with deglycating activities and methods of using same